CBPO
$117.00
China Biologic Produ
$.30
.26%
CBPO
Earnings Whisper ®
N/A
4th Quarter December 2019
Consensus:  $0.00
Revenue:  N/A
Wednesday
Feb 12
4:45 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CBPO reports earnings?
Beat
Meet
Miss

Where is CBPO's stock price going from here?
Up
Flat
Down
Stock chart of CBPO
Analysts
Summary of analysts' recommendations for CBPO
Score
Grade
Pivots
Resistance
$118.91
$118.41
$117.70

$117.20

Support
$116.49
$115.99
$115.28
Tweet
Growth
Description
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesBluebird BioSeattle GeneticsQiagen N.V.RepligenBioCryst PharmaceuticalsNovavax